A common sugar substitute has been shown to impair the cells that form the brain’s protective barrier.
By disrupting how those cells regulate blood flow and dissolve clots, the sweetener introduces a direct biological link to stroke risk that consumers rarely consider.
A lab warning sign
Inside the delicate lining of the brain’s smallest blood vessels, erythritol exposure altered the behavior of the very cells that guard neural tissue.
Working with cultured human brain microvascular endothelial cells, Professor Christopher A. DeSouza at the University of Colorado Boulder (CU Bolder) documented clear signs of dysfunction after short-term exposure to amounts comparable to a single sweetened drink.
Rather than maintaining balanced vessel signaling, the treated cells shifted toward a state associated with constriction and reduced protective capacity.
Those early cellular changes do not prove harm in living people, but they establish a focused biological pathway that demands closer scrutiny.
Barrier cells under strain
These brain vessel cells form much of the blood-brain barrier, a filter that controls what reaches brain tissue.
Tight connections between endothelial cells, the lining cells inside blood vessels, help stop toxins and germs from leaking through.
Damage to that lining can also disturb how blood moves, since the same cells control vessel relaxation and constriction.
When those controls fail in the brain, even a small clot can cut off oxygen fast and raise stroke danger.
A chemical stress surge
In the lab, erythritol pushed cells into oxidative stress, a buildup of reactive chemicals that harm cells.
That reaction increased free radicals, highly reactive molecules that damage proteins and membranes, while the cells scrambled to boost defenses.
Reactive oxygen production rose to about double the untreated level, at a dose designed to mimic a single sweetened drink.
Cells under that chemical pressure cannot keep their barriers tight, which could make brain vessels more fragile over time.
Signals steer blood flow
One of the clearest changes involved nitric oxide, a gas signal that relaxes blood vessels and supports steady flow.
Erythritol exposure led the cells to release less nitric oxide, so vessel walls would stay tighter during demand swings.
At the same time, endothelin-1, a signal that tightens blood vessels, rose by about 30% in treated cells.
With the relaxing signal down and the tightening signal up, brain microvessels could constrict when they should dilate.
When clots persist longer
Another warning appeared when the cells met a clotting signal that normally starts a cleanup response.
Healthy vessels release tissue plasminogen activator, a protein that helps dissolve blood clots, before a blockage grows dangerous.
After erythritol exposure, that clot-dissolving burst barely rose, while untreated cells increased release by about 25%.
Such blunted release could leave more clots intact in narrow brain vessels, raising ischemic stroke, a clot that blocks blood flow in the brain.
Human data raises alarms
Lab results matter more when they match patterns in real people, and erythritol already sits in that category.
“Erythritol, a common non-nutritive sweetener, is associated with increased risk of cardiovascular and cerebrovascular events,” wrote DeSouza.
In a large analysis, the top quarter for blood erythritol faced about double the 3-year event risk. Those studies cannot prove erythritol caused the harm, yet they make the lab damage harder to dismiss.
Why industry picked erythritol
Manufacturers use erythritol because it tastes close to sugar and does not spike blood glucose for most people.
As a sugar alcohol, a carbohydrate that tastes sweet but digests differently, it passes through the body with little energy.
In a 2023 World Health Organization guideline, the advice covered non-sugar sweeteners, but it excluded sugar alcohols like erythritol.
That exclusion helped the sweetener keep a healthy image, even as scientists kept looking for hidden downsides.
What regulators have said
Across the United States, the Food and Drug Administration, FDA, has allowed erythritol in foods and beverages.
In one FDA response letter, the agency accepted a company’s conclusion that erythritol is safe for intended uses.
FDA reviews focus on toxicology and exposure estimates, so they rarely test how a single ingredient affects a specific tissue.
Labels like “sugar-free” and “keto-friendly” can make erythritol feel like a sure bet, even when evidence gets complicated.
Next tests that matter
Cell-dish experiments can reveal early damage, but they cannot capture digestion, hormones, and repair systems working in a living body.
To bridge that gap, scientists are building models like organ-on-a-chip, tiny devices that mimic blood vessels under flow.
At CU Boulder, DeSouza called for longer testing and more realistic flow, since brain vessels respond to constant pressure changes.
Until those studies report, the current findings mark a plausible mechanism rather than a verdict on every can.
What changes now
The findings link a common sugar substitute to weaker brain vessel defenses and less control over blood flow and clots.
People who lean on keto or diabetic-friendly products may want to scan ingredients, and scientists will need better real-world exposure studies.
The study is published in the Journal of Applied Physiology.
